{"id":"bd-mdi-160-g","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Oral thrush"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Cough"},{"rate":"5-10%","effect":"Sore throat"},{"rate":"5-10%","effect":"Hoarseness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"BD MDI 160 µg contains a medication called fluticasone propionate, which is a corticosteroid that reduces inflammation in the airways. This helps to prevent symptoms of asthma and COPD, such as wheezing and shortness of breath.","oneSentence":"BD MDI 160 µg is a bronchodilator that works by relaxing the muscles in the airways to improve breathing in people with asthma or COPD.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:57:56.738Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Maintenance treatment of asthma"},{"name":"Maintenance treatment of COPD"}]},"trialDetails":[{"nctId":"NCT03847896","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered Dose Inhaler (BDA MDI/PT027) Used 4 Times Daily in Adults and Children 4 Years of Age or Older With Asthma","status":"COMPLETED","sponsor":"Bond Avillion 2 Development LP","startDate":"2019-03-20","conditions":"Asthma","enrollment":1001},{"nctId":"NCT02105012","phase":"PHASE2","title":"Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma","status":"COMPLETED","sponsor":"Pearl Therapeutics, Inc.","startDate":"2014-04-01","conditions":"Asthma","enrollment":147}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["PT008"],"phase":"phase_2","status":"active","brandName":"BD MDI 160 µg","genericName":"BD MDI 160 µg","companyName":"Pearl Therapeutics, Inc.","companyId":"pearl-therapeutics-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"BD MDI 160 µg is a bronchodilator that works by relaxing the muscles in the airways to improve breathing in people with asthma or COPD. Used for Maintenance treatment of asthma, Maintenance treatment of COPD.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}